Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2020

Open Access 01-12-2020 | Cardiac Tumor | Case report

The omitted symptoms challenge the diagnosis of right atrial myxoma: a case report

Authors: Shulun Ma, Qian Xu, Ruizheng Shi, Xin Zhang, Xuliang Chen

Published in: BMC Cardiovascular Disorders | Issue 1/2020

Login to get access

Abstract

Background

Cardiac myxoma (CM) is the most common type of primary cardiac tumors. The prevalence of primary cardiac tumors is 0.0017–0.28% in various autopsy studies. The clinical symptoms of CM which includes embolism, intracardiac obstruction, general or constitutional manifestations and infected myxoma are largely depended on the size, growing speed, location and pedicle length of the tumor. The following case reported a missed diagnostic case of a right atrial myxoma firstly presented digestive, systemic symptoms and immunologic disorder, leading to emergent tricuspid valves obstruction situation.

Case presentation

We reported a critical case of a 51-year-old female with CM was firstly admitted to the gastroenterology clinical department because of poor appetite, marked fatigability and weight loss for 2 months. The physician diagnosed her as chronic gastritis and treated her with some symptomatic treatment such as ilaprazole and magnesium aluminum carbonate. After months without definitive diagnosis, this right atrial myxoma grew into right ventricle and obstructed the tricuspid valves, causing her dyspnea, sweating, dizziness, feeling of impending death when she was sleeping. Transthoracic echocardiogram revealed a 6.1 × 4.2 × 3.7 cm2 mass adjacent to tricuspid valves. The patient underwent surgical excision and pathology revealed a primary cardiac myxoma.

Conclusion

This case reported a critical result of missed diagnosis of right atrial myxoma and showed its systematic symptoms and immunologic disorder, highlighting the importance of systematic examinations on patients. Furthermore, it appeals early diagnosis of CM and consideration of drug targets to suppress CM development.
Literature
2.
go back to reference Amano J, Kono T, Wada Y, Zhang T, Koide N, Fujimori M, et al. Cardiac myxoma: its origin and tumor characteristics. Ann Thorac Cardiovasc Surg. 2003;9(4):215–21.PubMed Amano J, Kono T, Wada Y, Zhang T, Koide N, Fujimori M, et al. Cardiac myxoma: its origin and tumor characteristics. Ann Thorac Cardiovasc Surg. 2003;9(4):215–21.PubMed
3.
go back to reference Li H, Guo H, Xiong H, Xu J, Wang W, Hu S. Clinical features and surgical results of right atrial Myxoma. J Card Surg. 2016;31(1):15–7.CrossRef Li H, Guo H, Xiong H, Xu J, Wang W, Hu S. Clinical features and surgical results of right atrial Myxoma. J Card Surg. 2016;31(1):15–7.CrossRef
4.
go back to reference Yokomuro H, Yoshihara K, Watanabe Y, Shiono N, Koyama N, Takanashi Y. The variations in the immunologic features and interleukin-6 levels for the surgical treatment of cardiac myxomas. Surg Today. 2007;37(9):750–3.CrossRef Yokomuro H, Yoshihara K, Watanabe Y, Shiono N, Koyama N, Takanashi Y. The variations in the immunologic features and interleukin-6 levels for the surgical treatment of cardiac myxomas. Surg Today. 2007;37(9):750–3.CrossRef
5.
go back to reference Larsson S, Lepore V, Kennergren C. Atrial myxomas: results of 25 years’ experience and review of the literature. Surgery. 1989;105(6):695–8.PubMed Larsson S, Lepore V, Kennergren C. Atrial myxomas: results of 25 years’ experience and review of the literature. Surgery. 1989;105(6):695–8.PubMed
6.
go back to reference Gosev I, Paic F, Duric Z, Gosev M, Ivcevic S, Jakus FB, et al. Cardiac myxoma the great imitators: comprehensive histopathological and molecular approach. Int J Cardiol. 2013;164(1):7–20.CrossRef Gosev I, Paic F, Duric Z, Gosev M, Ivcevic S, Jakus FB, et al. Cardiac myxoma the great imitators: comprehensive histopathological and molecular approach. Int J Cardiol. 2013;164(1):7–20.CrossRef
7.
go back to reference Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore). 2001;80(3):159–72.CrossRef Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore). 2001;80(3):159–72.CrossRef
8.
go back to reference Sarjeant JM, Butany J, Cusimano RJ. Cancer of the heart: epidemiology and management of primary tumors and metastases. Am J Cardiovasc Drugs. 2003;3(6):407–21.CrossRef Sarjeant JM, Butany J, Cusimano RJ. Cancer of the heart: epidemiology and management of primary tumors and metastases. Am J Cardiovasc Drugs. 2003;3(6):407–21.CrossRef
9.
go back to reference Citro R, Masiello P, Bossone E, Provenza G, Mastrogiovanni G, Baldi C, et al. Giant left atrial myxoma: an unusual cause of acute pulmonary edema. J Am Soc Echocardiogr. 2008;21(8):971–8.CrossRef Citro R, Masiello P, Bossone E, Provenza G, Mastrogiovanni G, Baldi C, et al. Giant left atrial myxoma: an unusual cause of acute pulmonary edema. J Am Soc Echocardiogr. 2008;21(8):971–8.CrossRef
10.
go back to reference Bjessmo S, Ivert T. Cardiac myxoma: 40 years’ experience in 63 patients. Ann Thorac Surg. 1997;63(3):697–700.CrossRef Bjessmo S, Ivert T. Cardiac myxoma: 40 years’ experience in 63 patients. Ann Thorac Surg. 1997;63(3):697–700.CrossRef
11.
go back to reference Barh D, Kumar A, Chatterjee S, Liloglou T. Molecular features, markers, drug targets, and prospective targeted therapeutics in cardiac myxoma. Curr Cancer Drug Targets. 2009;9(6):705–16.CrossRef Barh D, Kumar A, Chatterjee S, Liloglou T. Molecular features, markers, drug targets, and prospective targeted therapeutics in cardiac myxoma. Curr Cancer Drug Targets. 2009;9(6):705–16.CrossRef
Metadata
Title
The omitted symptoms challenge the diagnosis of right atrial myxoma: a case report
Authors
Shulun Ma
Qian Xu
Ruizheng Shi
Xin Zhang
Xuliang Chen
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2020
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-020-01413-4

Other articles of this Issue 1/2020

BMC Cardiovascular Disorders 1/2020 Go to the issue